Showing results (1-10 of 1,574) with videos related to
Sort By:
Pageof 158
Pharmacogenomics|August 12, 2009
Pharmacogenomics of CYP3A: considerations for HIV treatmentSukhwinder S Lakhman, Qing Ma, Gene D MorsePharmacogenomics|October 11, 2007
Advances in pharmacogenomics of antiretrovirals: an updateQing Ma, Dan Brazeau, Alan Forrest, et al.Clinical Pharmacology in Drug Development|March 7, 2017
Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment MedicationsCindy J Bednasz, Charles S Venuto, Qing Ma, et al.Topics in HIV Medicine : a Publication of the International AIDS Society, USA|June 30, 2007
HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countriesCharles C Maponga, Qing Ma, Judianne C Slish, et al.Expert Opinion on Drug Metabolism & Toxicology|April 13, 2007
Drug interactions between proton pump inhibitors and antiretroviral drugsSarah M McCabe, Patrick F Smith, Qing Ma, et al.Journal of Pharmacy Practice|June 30, 2011
Within-patient atazanavir trough concentration monitoring in HIV-1-infected patientsRustin D Crutchley, Qing Ma, Adel Sulaiman, et al.AIDS Research and Treatment|April 17, 2012
The impact of herbal drug use on adverse drug reaction profiles of patients on antiretroviral therapy in zimbabweTinashe Mudzviti, Charles C Maponga, Star Khoza, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 27, 2012
Disulfiram metabolite S-methyl-N,N-diethylthiocarbamate quantitation in human plasma with reverse phase ultra performance liquid chromatography and mass spectrometryJill Hochreiter, Elinore F McCance-Katz, Jill Lapham, et al.AIDS Research and Treatment|August 20, 2013
Comparative Effectiveness of Darunavir 1,200 mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced PatientsJames M Mikula, Chiu-Bin Hsiao, Joshua R Sawyer, et al.Journal of Pharmaceutical and Biomedical Analysis|May 1, 2018
Development and validation of an LC-MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluidAndrew J Ocque, Colleen E Hagler, Gene D Morse, et al.Pageof 158